Search for: "Glenmark Pharmaceuticals Ltd."
Results 21 - 36
of 36
Sorted by Relevance
|
Sort by Date
30 Jun 2010, 5:52 am
Glenmark Generics Inc. [read post]
16 Jun 2010, 3:02 pm
Sun Pharmaceutical Industries Ltd. et al. [read post]
17 Nov 2010, 1:48 am
General Where in the world is pharmaceutical innovation? [read post]
2 Nov 2007, 11:00 pm
Ltd over use of information by former employee (Rouse & Co.), China enacts amendment to TRIPS allowing compulsory patent licence system when public health emergencies occur (Rouse & Co.), (IPDragon), (IPKat), (ChinaDaily), IP Injunctions on the rise in China (Rouse & Co.) [read post]
9 Dec 2009, 3:59 pm
Ltd. et al. v. [read post]
26 Apr 2010, 12:31 am
Ltd. v. [read post]
12 Aug 2009, 8:09 am
(Spicy IP) UK: Hindsight going forward: taking the risk factor into account: Lilly Icos, Pfizer Enterprises, Merck, AstraZeneca & Ors v 8pm Chemists & Ors (IP finance) US: Gene patenting debate continues – round two (Patent Docs) US: Follow-on biologics news briefs – no 7 (Patent Docs) US: BIO urges Supreme Court to reject rigid Bilski rule (PatentBIOtech) US: Cargill withdraws patent infringement case before ITC against Nantong Foreign Medicines & Health… [read post]
30 Jun 2013, 1:12 pm
The petition is more or less similar to Super Cassettes Industries Ltd. [read post]
27 May 2010, 3:20 am
Lupin Ltd. [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US: District Court of New Jersey… [read post]
18 Jul 2008, 8:34 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
5 Oct 2023, 9:01 pm
For example, when the Antitrust Division recently announced DPAs with two pharmaceutical companies, Teva and Glenmark, we determined that a monetary penalty alone was not sufficient. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
24 Oct 2023, 9:50 am
Pix Credit Charlie Chaplin, "Modern Times" If you’ve been paying attention to the policies we’ve implemented over the past two years, you’ve probably noticed that I talk a lot about empowering general counsels and compliance officers – to make the case in the board room and the c-suite for investments in compliance – and to make the case that investing in strong compliance programs is good for business. [read post]
